KETOPROFEN SUPPOSITORIES 50 MG — DIN 02236965
KETOPROFEN : 50 MG · PHARMEL INC · SUPPOSITORY · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is KETOPROFEN SUPPOSITORIES?
KETOPROFEN SUPPOSITORIES 50 MG contains KETOPROFEN : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02236965, held by PHARMEL INC, supplied as SUPPOSITORY for RECTAL administration. Health Canada currently lists it as cancelled pre market, status dated 12-Sep-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Ketoprofen in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Ketoprofen, across 36 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 4 | 3 | KETOPROFEN, KETOPROFEN SR, KETOPROFEN-E | Sourceable in Canada |
| AVENTIS PHARMA INC | 8 | 0 | ORUDIS 100, ORUDIS 50, ORUDIS CAP 50MG, ORUDIS E-100, ORUDIS E-50, +3 more | No marketed DIN |
| PHARMASCIENCE INC | 5 | 0 | PMS-KETOPROFEN, PMS-KETOPROFEN CAPSULES, PMS-KETOPROFEN E-100 - ECT, PMS-KETOPROFEN E-50 - ECT 50MG | No marketed DIN |
| RHODIAPHARM INC | 4 | 0 | RHODIS CAP 50MG, RHODIS SR 200MG, RHOVAIL 150, RHOVAIL 200 | No marketed DIN |
| NOVOPHARM LIMITED | 3 | 0 | NOVO-KETO SUPPOSITORIES 100MG, NOVO-KETO-EC TAB 100MG, NOVO-KETO-EC TAB 50MG | No marketed DIN |
| NU-PHARM INC | 3 | 0 | NU-KETOPROFEN CAP 50MG, NU-KETOPROFEN-E ECT 100MG, NU-KETOPROFEN-E ECT 50MG | No marketed DIN |
| PRO DOC LIMITEE | 3 | 0 | KETOPROFEN-E ECT 100MG, KETOPROFEN-E ECT 50MG, KETOPROFEN-SR - SRT 200MG | No marketed DIN |
| SANOFI-AVENTIS CANADA INC | 3 | 0 | RHODIS, RHODIS EC | No marketed DIN |
| PHARMEL INC | 2 | 0 | KETOPROFEN SUPPOSITORIES | No marketed DIN |
| TECHNILAB PHARMA INC. | 1 | 0 | ORAFEN - SUP RT 100MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MG |
|---|---|
| Dosage form | SUPPOSITORY |
| Route | RECTAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Ketoprofen |
|---|---|
| ATC code | M01AE03 |
| AHFS class | 28:08.04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02236965 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2236965 |
| Brand name | KETOPROFEN SUPPOSITORIES |
| Generic / active ingredient | KETOPROFEN : 50 MG |
| Market authorization holder | PHARMEL INC |
| Health Canada schedule | Prescription |
| ATC code | M01AE03 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M01AE |
| Current status | CANCELLED PRE MARKET |
| Status date | 12-Sep-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 36 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| KETOPROFEN SR | 200 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 02172577 |
| KETOPROFEN-E | 50 MG | TABLET (ENTERIC-COATED) | AA PHARMA INC | MARKETED | 00790435 |
| KETOPROFEN-E | 100 MG | TABLET (ENTERIC-COATED) | AA PHARMA INC | MARKETED | 00842664 |
| KETOPROFEN | 50 MG | CAPSULE | AA PHARMA INC | DORMANT | 00790427 |
| KETOPROFEN SUPPOSITORIES | 100 MG | SUPPOSITORY | PHARMEL INC | CANCELLED POST MARKET | 02237011 |
| KETOPROFEN-E ECT 100MG | 100 MG | TABLET (ENTERIC-COATED) | PRO DOC LIMITEE | CANCELLED POST MARKET | 02084198 |
| KETOPROFEN-E ECT 50MG | 50 MG | TABLET (ENTERIC-COATED) | PRO DOC LIMITEE | CANCELLED POST MARKET | 02084171 |
| KETOPROFEN-SR - SRT 200MG | 200 MG | TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | CANCELLED POST MARKET | 02210487 |
| NOVO-KETO SUPPOSITORIES 100MG | 100 MG | SUPPOSITORY | NOVOPHARM LIMITED | CANCELLED POST MARKET | 02156083 |
| NOVO-KETO-EC TAB 100MG | 100 MG | TABLET (ENTERIC-COATED) | NOVOPHARM LIMITED | CANCELLED POST MARKET | 01981536 |
2 · Same class — other molecules in ATC M01AE
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ibuprofen | ACTIPROFEN - CAPLET 200MG · ADVIL 12 HOUR · ADVIL ARTHRITIS PAIN · ADVIL CAPLETS · +107 more | 143 | 46 | Yes |
| Naproxen | ALEVE BACK AND BODY PAIN · ALEVE CAPLETS · ALEVE LIQUID GELS · ALEVE NIGHTTIME · +81 more | 125 | 31 | Yes |
| Ibuprofen, Combinations | ADVIL COLD & FLU · ADVIL COLD & SINUS CONVENIENCE PACK · ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS · ADVIL COLD & SINUS LIQUI-GELS · +36 more | 40 | 13 | Yes |
| Naproxen And Esomeprazole | MYLAN-NAPROXEN/ESOMEPRAZOLE MR · VIMOVO | 4 | 4 | Yes |
| Ketoprofen | KETOPROFEN · KETOPROFEN SR · KETOPROFEN SUPPOSITORIES · KETOPROFEN-E · +28 more | 36 | 3 | Yes |
| Tiaprofenic Acid | ALBERT TIAFEN SR · ALBERT TIAFEN TAB 200MG · ALBERT TIAFEN TAB 300MG · APO-TIAPROFENIC TABLETS -300MG · +15 more | 25 | 2 | Yes |
| Flurbiprofen | ANSAID TABLETS 100 MG · ANSAID TABLETS 50 MG · FLURBIPROFEN · FLURBIPROFEN-100 TAB 100MG · +12 more | 19 | 2 | Yes |
| Oxaprozin | APO-OXAPROZIN · DAYPRO · RHOXAL-OXAPROZIN | 3 | 0 | Not in Canada |
| Fenoprofen | NALFON CAP 300MG · NALFON TAB 600MG | 2 | 0 | Not in Canada |
| Naproxen And Diphenhydramine | PAIN RELIEVER & SLEEP AID | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M01AB | Diclofenac · Diclofenac, Combinations · Etodolac · Indometacin · Ketorolac · +2 more | 170 | 38 |
| M01AH | Celecoxib · Rofecoxib | 72 | 30 |
| M01AC | Meloxicam · Piroxicam · Tenoxicam | 67 | 14 |
| M01AG | Mefenamic Acid | 7 | 1 |
| M01AX | Nabumetone | 12 | 1 |
| M01AA | Oxyphenbutazone · Phenylbutazone · Phenylbutazone, Combinations | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is KETOPROFEN SUPPOSITORIES called?
The same molecule, Ketoprofen, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| KETONAL | Latin | Czechia |
| KETONAL FORTE | Latin | Czechia |
| KETONAL PROLONG | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Ketoprofen called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Ketoprofen, published to help those searches reach this page.
| Language | Ketoprofen |
|---|---|
| Arabic العربية | كيتوبروفين |
| Chinese (Simplified) 简体中文 | 酮洛芬 |
| Russian Русский | Кетопрофен |
| Spanish Español | Ketoprofeno |
| French Français | Kétoprofène |
| Japanese 日本語 | ケトプロフェン |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.